參考文獻(xiàn)/References:
[1] Vasuri F,Malvi D,Bonora S,et a1.From large to small:the immunohistochemical panel in the diagnosis of early hepa- tocellular carcinoma[J].Histopathology,2018,72(3):414-422.
[2] 李文生,解燕川,谷雷,等.腫瘤拒絕抗原1在胃癌組織中的表達(dá)及其意義[J].中華實(shí)驗(yàn)外科雜志,2016,33(2):315-317.
[3] 解燕川,劉瓊瓊,任利群,等.肌動(dòng)蛋白凝膠蛋白在胃癌組織中的表達(dá)及臨床意義[J].中華實(shí)驗(yàn)外科雜志,2016,33(5):1339-1341.
[4] 李文生,劉偉峰,宋俊鑫,等.垂體腺苷酸環(huán)化酶在胃癌組織中的表達(dá)及其與臨床病理特征的關(guān)系[J].中華實(shí)驗(yàn)外科雜志,2016,33(5):1333-1335.
[5] Chen X,Ba Y,Ma L,et al.Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases [J].Cell Res,2008,18(10):997-1006.
[6] Hawkins R A, Vina J R.How glutamate is managed by the blood-brain barrier[J]. Biology(Basel), 2016, 5(4):37.
[7] Hawkins R A.The blood-brain barrier and glutamate[J]. Am J Clin Nutr, 2009, 90(3): 867-874.
[8] Castegna A,Menga A.Glutamine synthetase: localization dictates outcome[J]. Genes,2018, 9(2):108.
[9] Loeppen S,Schrieider D,Gaunitz F,et a1.Over expression of glutamine synthetase is associated with β-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital[J].Cancer Research,2002(62):5685-5688.
[10] Nguyen T V, Lee J E, Sweredoski M J, et al.Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon[J]. Molecular cell,2016,61(6):809-820.